PMM2 and peripheral neuropathy: Based on structure–activity relationships, we found that epalrestat, a generic diabetic peripheral neuropathy drug and the only safe aldose reductase inhibitor (ARI) approved for use in humans (Hotta et al., 2006), is a first-in-class PMM2 enzyme activator.